Association of OPRM1 A118G variant with the relative reinforcing value of nicotine.
paper
Cited
Public
Unavailable
- Authors
- Ray, R; Jepson, C; Patterson, F; Strasser, A; Rukstalis, M; Perkins, K; Lynch, K G; O'Malley, S; Berrettini, W H; Lerman, C
- Year
- 2006
- Journal
- Psychopharmacology
- PMID
- 16960700
- DOI
- 10.1007/s00213-006-0504-2
RATIONALE: The endogenous opioid system has been implicated in substance abuse and response to pharmacotherapies for nicotine and alcohol addiction. We examined (1) the association of the functional OPRM1 A118G variant with the relative reinforcing value of nicotine and (2) the main and interacting effects of the mu-opioid receptor antagonist naltrexone on nicotine reinforcement. METHODS: In a within-subject, double-blind human laboratory study, 30 smokers of each OPRM1 genotype (A/A vs. A/G or G/G) participated in two experimental sessions following 4 days of orally administered naltrexone 50 mg or placebo. Participants completed a validated assessment of the relative reinforcing value of nicotine. This cigarette choice paradigm assesses self-administration of 0.6 mg nicotine vs. 0.05 mg (denicotinized) cigarettes after a brief period of nicotine abstinence. RESULTS: The relative reinforcing value of nicotine (number of nicotine cigarette puffs) was predicted by a significant OPRM1 by gender interaction. Among women, the low-activity G allele (A/G and G/G) was associated with a reduced reinforcing value of nicotine; among male smokers, there was no association with genotype. Smokers carrying a G allele were also significantly less likely to differentiate the nicotine vs. denicotinized cigarettes by subjective ratings of satisfaction and strength. No evidence for an effect of naltrexone on nicotine reinforcement was found in the overall sample or in the genotype or gender subgroups. CONCLUSIONS: This study provides initial evidence for an association of the OPRM1 A118G variant with nicotine reinforcement in women.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Acute nicotine reinforcement requires ability to discriminate the stimulus effects of nicotine. | Perkins KA | β | 2022 | β |
| A systems omics-based approach to decode substance use disorders and neuroadaptations. | Veerappa A et al. | β | 2021 | β |
| Translational Research in Nicotine Addiction. | Fisher ML et al. | β | 2021 | β |
| A Forced-Choice Procedure to Assess the Acute Relative Reinforcing Effects of Nicotine Dose per se in Humans. | Perkins KA et al. | β | 2020 | β |
| Haplotype-Based Association and In Silico Studies of OPRM1 Gene Variants with Susceptibility to Opioid Dependence Among Addicted Iranians Undergoing Methadone Treatment. | Tolami HF et al. | β | 2020 | β |
| Significant association of mu-opioid receptor 1 haplotype with tobacco smoking in healthy control subjects but not in patients with schizophrenia and alcohol dependence. | Konjevod M et al. | β | 2020 | β |
| Lack of Association between Opioid-Receptor Genotypes and Smoking Cessation Outcomes in a Randomized, Controlled Naltrexone Trial. | Roche DJO et al. | β | 2019 | β |
| Targeting opioid dysregulation in depression for the development of novel therapeutics. | Browne CA et al. | β | 2019 | β |
| Defining Substance Use Disorders: The Need for Peripheral Biomarkers. | Bough KJ et al. | β | 2018 | β |
| Evaluation of menthol per se on acute perceptions and behavioral choice of cigarettes differing in nicotine content. | Perkins KA et al. | β | 2018 | β |
| Focusing on the Opioid System for Addiction Biomarker Discovery. | Belzeaux R et al. | β | 2018 | β |
| Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment. | Bozinoff N et al. | β | 2018 | β |
| Association of opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) with nicotine dependence. | Kong X et al. | β | 2017 | β |
| Endogenous opioid system: a promising target for future smoking cessation medications. | Norman H et al. | β | 2017 | β |
| Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism. | Browne CA et al. | β | 2017 | β |
| Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder. | Hirasawa-Fujita M et al. | β | 2017 | β |
| Subjective experiences at first use of cigarette, e-cigarettes, hookah, and cigar products among Texas adolescents. | Mantey DS et al. | β | 2017 | β |
| A gene-by-sex interaction for nicotine reward: evidence from humanized mice and epidemiology. | Bernardi RE et al. | β | 2016 | β |
| Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts. | Schwantes-An TH et al. | β | 2016 | β |
| Can repetitive mental simulation of smoking engender habituation? | Audrain-McGovern J et al. | β | 2016 | β |
| The impact of flavoring on the rewarding and reinforcing value of e-cigarettes with nicotine among young adult smokers. | Audrain-McGovern J et al. | β | 2016 | β |
| To quit or not: Vulnerability of women to smoking tobacco. | Park SJ et al. | β | 2016 | β |
| Translational Research on Nicotine Dependence. | Falcone M et al. | β | 2016 | β |
| Advances in nicotine research in Addiction Biology. | Bernardi RE | β | 2015 | β |
| Functional mu opioid receptor polymorphism (OPRM1 A(118) G) associated with heroin use outcomes in Caucasian males: A pilot study. | Woodcock EA et al. | β | 2015 | β |
| Increased mesolimbic cue-reactivity in carriers of the mu-opioid-receptor gene OPRM1 A118G polymorphism predicts drinking outcome: a functional imaging study in alcohol dependent subjects. | Bach P et al. | β | 2015 | β |
| Parental smoke exposure and the development of nicotine craving in adolescent novice smokers: the roles of DRD2, DRD4, and OPRM1 genotypes. | Kleinjan M et al. | β | 2015 | β |
| Regional brain [(11)C]carfentanil binding following tobacco smoking. | Domino EF et al. | β | 2015 | β |
| Sex differences in acute hormonal and subjective response to naltrexone: The impact of menstrual cycle phase. | Roche DJ et al. | β | 2015 | β |
| Sex differences in resting state brain function of cigarette smokers and links to nicotine dependence. | Beltz AM et al. | β | 2015 | β |
| ΞΌ-Opioid receptor gene (OPRM1) polymorphism in patients with breast cancer. | CieΕliΕska A et al. | β | 2015 | β |
| Association of smoking with ΞΌ-opioid receptor availability before and during naltrexone blockade in alcohol-dependent subjects. | Weerts EM et al. | β | 2014 | β |
| Impact of tobacco outlet density and proximity on smoking cessation: a longitudinal observational study in two English cities. | Han T et al. | β | 2014 | β |
| Initial responses to the first dose of nicotine in novel smokers: the role of exposure to environmental smoking and genetic predisposition. | Schuck K et al. | β | 2014 | β |
| Pharmacogenetics of OPRM1. | Crist RC et al. | β | 2014 | β |
| Systematic review and meta-analysis of opioid antagonists for smoking cessation. | David SP et al. | β | 2014 | β |
| Consequences of the 118A>G polymorphism in the OPRM1 gene: translation from bench to bedside? | Mura E et al. | β | 2013 | β |
| Dual growth of adolescent smoking and drinking: evidence for an interaction between the mu-opioid receptor (OPRM1) A118G polymorphism and sex. | Kleinjan M et al. | β | 2013 | β |
| NKAIN1-SERINC2 is a functional, replicable and genome-wide significant risk gene region specific for alcohol dependence in subjects of European descent. | Zuo L et al. | β | 2013 | β |
| Opioid antagonists for smoking cessation. | David SP et al. | β | 2013 | β |
| Opioid receptor types involved in the development of nicotine physical dependence in an invertebrate (Planaria) model. | Raffa RB et al. | β | 2013 | β |
| OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: a cross sectional study. | Chen YT et al. | β | 2013 | β |
| A systematic review of the A118G (Asn40Asp) variant of OPRM1 in relation to smoking initiation, nicotine dependence and smoking cessation. | Verhagen M et al. | β | 2012 | β |
| Close association between A118G single nucleotide polymorphism and opioid, alcohol, and nicotine dependence. | Kapoor S | β | 2012 | β |
| Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients. | Wang SC et al. | β | 2012 | β |
| Influence of the OPRM1 A118G polymorphism on alcohol-induced euphoria, risk for alcoholism and the clinical efficacy of naltrexone. | Setiawan E et al. | β | 2012 | β |
| Pain intensity the first year after lumbar disc herniation is associated with the A118G polymorphism in the opioid receptor mu 1 gene: evidence of a sex and genotype interaction. | Olsen MB et al. | β | 2012 | β |
| Quantifying reinforcement value and demand for psychoactive substances in humans. | Heinz AJ et al. | β | 2012 | β |
| Tobacco smoking produces greater striatal dopamine release in G-allele carriers with mu opioid receptor A118G polymorphism. | Domino EF et al. | β | 2012 | β |
| Zebrafish: a model for the study of addiction genetics. | Klee EW et al. | β | 2012 | β |
| ΞΌ-Opioid receptor availability in the amygdala is associated with smoking for negative affect relief. | Falcone M et al. | β | 2012 | β |
| Activation of the opioid ΞΌ1, but not Ξ΄ or ΞΊ, receptors is required for nicotine reinforcement in a rat model of drug self-administration. | Liu X et al. | β | 2011 | β |
| Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. | Ray R et al. | β | 2011 | β |
| OPRM1 gene variation influences hypothalamic-pituitary-adrenal axis function in response to a variety of stressors in rhesus macaques. | Schwandt ML et al. | β | 2011 | β |
| Pharmacogenomics of the human Β΅-opioid receptor. | Kasai S et al. | β | 2011 | β |
| Pilot study examining the frequency of several gene polymorphisms involved in morphine pharmacodynamics and pharmacokinetics in a morbidly obese population. | Lloret Linares C et al. | β | 2011 | β |
| The role of impulsivity in the aetiology of drug dependence: reward sensitivity versus automaticity. | Hogarth L | β | 2011 | β |
| Acute HPA axis response to naltrexone differs in female vs. male smokers. | Roche DJ et al. | β | 2010 | β |
| Addressing tobacco use disorder in smokers in early remission from alcohol dependence: the case for integrating smoking cessation services in substance use disorder treatment programs. | Kalman D et al. | β | 2010 | β |
| Common and unique biological pathways associated with smoking initiation/progression, nicotine dependence, and smoking cessation. | Wang J et al. | β | 2010 | β |
| Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system. | Berrendero F et al. | β | 2010 | β |
| Nicotine reduction revisited: science and future directions. | Hatsukami DK et al. | β | 2010 | β |
| OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models. | Mague SD et al. | β | 2010 | β |
| The Role of Genetics in Nicotine Dependence: Mapping the Pathways from Genome to Syndrome. | Mackillop J et al. | β | 2010 | β |
| Acute responses to nicotine and smoking: implications for prevention and treatment of smoking in lower SES women. | Perkins KA | β | 2009 | β |
| A micro opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients. | Kim SG et al. | β | 2009 | β |
| Discriminative stimulus effects of nicotine in humans. | Perkins KA | β | 2009 | β |
| Genome-wide association study of smoking initiation and current smoking. | Vink JM et al. | β | 2009 | β |
| Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases. | Quaak M et al. | β | 2009 | β |
| Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid dependence: A meta-analysis. | Coller JK et al. | β | 2009 | β |
| Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior. | Mague SD et al. | β | 2009 | β |
| Naltrexone attenuation of conditioned but not primary reinforcement of nicotine in rats. | Liu X et al. | β | 2009 | β |
| Nicotine dependence: biology, behavior, and treatment. | Ray R et al. | β | 2009 | β |
| Nicotine withdrawal sensitivity, linkage to chr6q26, and association of OPRM1 SNPs in the SMOking in FAMilies (SMOFAM) sample. | Hardin J et al. | β | 2009 | β |
| Sex differences in nicotine reinforcement and reward: influences on the persistence of tobacco smoking. | Perkins KA | β | 2009 | β |
| Sex heterogeneity in pharmacogenetic smoking cessation clinical trials. | Schnoll RA et al. | β | 2009 | β |
| Transdisciplinary Tobacco Use Research Centers: research achievements and future implications. | Baker TB et al. | β | 2009 | β |
| Variability in initial nicotine sensitivity due to sex, history of other drug use, and parental smoking. | Perkins KA et al. | β | 2009 | β |
| A placebo-controlled trial of modafinil for nicotine dependence. | Schnoll RA et al. | β | 2008 | β |
| Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes. | Filbey FM et al. | β | 2008 | β |
| Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood. | Perkins KA et al. | β | 2008 | β |
| Gene and gene by sex associations with initial sensitivity to nicotine in nonsmokers. | Perkins KA et al. | β | 2008 | β |
| Initial nicotine sensitivity in humans as a function of impulsivity. | Perkins KA et al. | β | 2008 | β |
| Neuroimaging, genetics and the treatment of nicotine addiction. | Ray R et al. | β | 2008 | β |
| Nicotine abstinence-induced cerebral blood flow changes by genotype. | Wang Z et al. | β | 2008 | β |
| Association of the mu-opioid receptor gene with smoking cessation. | MunafΓ² MR et al. | β | 2007 | β |
| CREB1 haplotypes and the relative reinforcing value of nicotine. | Ray R et al. | β | 2007 | β |
| Endogenous opiates and behavior: 2006. | Bodnar RJ | β | 2007 | β |
| Genetics and smoking cessation improving outcomes in smokers at risk. | Lerman CE et al. | β | 2007 | β |
| Pharmacogenetics and smoking cessation with nicotine replacement therapy. | Ray R et al. | β | 2007 | β |
| Pharmacogenetics of the Β΅-opioid receptor and the treatment of addictions. | Ray LA et al. | β | 2007 | β |
| The biological bases of nicotine and alcohol co-addiction. | Li TK et al. | β | 2007 | β |
| Translational research in medication development for nicotine dependence. | Lerman C et al. | β | 2007 | β |
| Can pharmacogenetics help smokers quit? | MunafΓ² M et al. | β | 2006 | β |
| Opioid antagonists for smoking cessation. | David S et al. | β | 2006 | β |